This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Stage III or IV Melanoma
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate pharmacodynamic changes of BMS-936559 treatment on the biomarkers measured in the peripheral blood and tumor tissues of subjects with unresectable Stage III or IV Melanoma.

Provided treatments

  • Biological: BMS-936559 (Anti-PD-L1)
  • Biological: BMS-936559 (Anti-PD-L1)
  • Biological: BMS-936559 (Anti-PD-L1)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455103. The sponsor of the trial is Bristol-Myers Squibb and it is looking for 0 volunteers for the current phase.
Official trial title:
A Phase I Study of the Biologic Effects of BMS-936559 Treatment in Subjects With Unresectable Stage III or IV Melanoma